• MiR-24-3p, Sp1/PI3K, and Doxorubicin Heart Failure

  2026-09-16

  The reference study identifies miR-24-3p as a regulator of doxorubicin-induced cardiac injury and links its effects to the Sp1/PI3K signaling pathway. Using rat and H9c2 cell models, the authors show that miR-24-3p silencing reduces apoptosis and oxidative stress, providing a mechanistic framework for studying transcriptional control in heart failure.

• Direct Mouse Genotyping Kit Plus for EP4 Models

  2026-09-16

  Accelerate genotype confirmation in EP4 and ApoE mouse colonies with a direct tissue-to-PCR workflow that minimizes purification steps. The kit is especially useful for transgene detection, conditional allele screening, and rapid quality control before mechanistic atherosclerosis studies.

• Masitinib (AB1010) Workflow Guide

  2026-09-15

  Masitinib (AB1010; SKU A2942) provides a DMSO-compatible research tool for focused KIT, PDGFRα, and PDGFRβ inhibition in cancer biology, mast cell, and inflammatory workflows. It is suitable for biochemical and cellular assays but should not be used as a substitute for clinical dosing evidence, broad-spectrum kinase inhibition, or aqueous- or ethanol-based protocols.

• LDH Cytotoxicity Assay Kit: Practical QC Guide

  2026-09-15

  The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive colorimetric method for cell cytotoxicity measurement and cell damage quantification through LDH released into culture medium. It is suited to comparative in vitro studies, but LDH release alone should not identify apoptosis or another death pathway, and the assay should not be used as a standalone in vivo or clinical test.

• EdU Flow Cytometry Assay Kits (Cy5): S-Phase

  2026-09-14

  EdU Flow Cytometry Assay Kits (Cy5) measure DNA synthesis during S phase through copper-catalyzed azide-alkyne cycloaddition (CuAAC). The K1078 workflow provides a denaturation-free, Cy5-based readout for flow cytometry cell proliferation assays and can support validation of cell-cycle changes reported in diabetic foot ulcer models.

• Chlorambucil Workflows for In Vitro Drug Response

  2026-09-14

  Build more informative Chlorambucil experiments by separating growth inhibition from actual cell killing. This practical guide covers solvent handling, time-resolved viability and death measurements, model-specific applications, and troubleshooting for leukemia, glioma, endothelial, and mesenchymal cell systems.

• EDC.HCl: Practical Coupling Workflow

  2026-09-13

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a research reagent only; the dossier provides no in vivo or clinical data, and its solutions should not be stored long term.

• Triacetin Digestion and Absorption: New Rat Study

  2026-09-12

  A rat study shows that orally administered triacetin is rapidly degraded in the upper gastrointestinal tract and absorbed primarily as acetate and glycerol rather than reaching the colon intact. The findings identify triacetin as both a metabolic substrate and a potential regulator of hepatic AMPK-associated lipid metabolism, while also defining important limits for translation to human nutrition and disease research.

• Proteinase K for DNA Prep and Assay Controls

  2026-09-11

  Proteinase K combines broad protein digestion with compatibility across DNA isolation and protease-assay workflows. This guide shows how to use it for nuclease removal, high-quality genomic DNA preparation, and selectivity controls inspired by SARS-CoV-2 3CLpro inhibitor research.

• ARCA Cy5 EGFP mRNA (5-moUTP): A Benchmark

  2026-09-11

  A mechanistic and translational framework for using ARCA Cy5 EGFP mRNA (5-moUTP) to distinguish mRNA uptake, intracellular localization, release, and protein expression during delivery-system development.

• Eicosapentaenoic Acid (EPA) in Cell Assays

  2026-09-10

  Learn how Eicosapentaenoic Acid (EPA), SKU B3464, can be integrated into cell viability, migration, and cardiovascular research workflows with tighter control of concentration, vehicle, storage, and interpretation. This scenario-based guide distinguishes product-supported evidence from practical assay recommendations.

• IDH2, α-KG, and HIF-1α in Colorectal Cancer

  2026-09-10

  The reference study identifies mitochondrial IDH2 as a driver of colorectal cancer metabolic reprogramming, linking reductive citrate-cycle activity with α-ketoglutarate availability, HIF-1A stabilization, glycolysis, and tumor progression. Its combined genetic, pharmacological, cellular, and animal-model approach provides a framework for studying how mitochondrial metabolism and hypoxia signaling jointly sustain CRC growth.

• iTBS in SCA3 Mice: Motor and Molecular Effects

  2026-09-09

  A 2026 study in The Cerebellum shows that intermittent theta-burst stimulation (iTBS), but not continuous theta-burst stimulation (cTBS) to the same extent, improves coordination and modifies cerebellar pathology in SCA3/MJD mice. The work is notable for linking behavioral outcomes with ataxin-3 aggregation, neuroinflammatory markers, cytokine changes, and autophagy-related proteins.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-09-09

  The eLife study developed a scalable workflow that combines high-content imaging, induced pluripotent stem cell-derived cardiomyocytes, and deep learning to detect cardiotoxic phenotypes across compound libraries. Its single-parameter scoring strategy supports early safety triage, while the reported limitations show why image-based predictions should be followed by mechanistic and electrophysiological validation.

• Nanoparticle PTEN mRNA Reverses Trastuzumab Resistance

  2026-09-08

  Dong and colleagues developed a tumor-microenvironment-responsive nanoparticle platform for systemic PTEN mRNA delivery in trastuzumab-resistant HER2-positive breast cancer models. By restoring PTEN expression and inhibiting PI3K/Akt signaling, the approach improved responsiveness to trastuzumab while illustrating how stimulus-responsive delivery can address resistance downstream of HER2.

8073 records 1/539 page Next 12345 下5页 Last page